Virginia Commonwealth University Health System

Richmond, Virginia 23298-5058

4 studies enrolling now · 53 studies all time

What they study most

Acute Kidney Injury, Acute Lung Injury, Acute Myocardial Infarction (AMI), Acute Respiratory Distress Syndrome, Adult, Adhesions, Ambulatory Surgery, Amyloid Cardiomyopathy, Transthyretin-Related, Ascites, Atrial Fibrillation, Bleeding, Bradycardia, CIED Related Infection

Studies at this site

• 4D-710 in Adult Patients With Cystic Fibrosis — Recruiting now
• Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD) — Recruiting now
• Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) — Recruiting now
• CHAMPION-AF Clinical Trial — Running, not enrolling
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• Add-on Reparixin in Adult Patients With ARDS — Completed
• ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study — Completed
• Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity — Completed
• Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants — Running, not enrolling
• Destination Therapy Post Approval Study — Running, not enrolling
• Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation — Completed
• Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
• The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation — Completed
• OCS Liver PROTECT Continued Access Protocol — Completed
• OCS Liver PROTECT Continuation Post-Approval Study — Completed
• A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury — Completed
• OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study — Completed
• AdaptResponse Clinical Trial — Completed
• A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms — Completed
• A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin — Completed
• Evaluation of Left Ventricular AutoThreshold — Completed
• Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology — Completed
• Imaging Study of Lead Implant for His Bundle Pacing — Completed
• The Global cVAD Study — Status unconfirmed
• Longitudinal Surveillance Study of the 4-SITE Lead/Header System — Completed
• ENABLE MRI (Magnetic Resonance Imaging) — Completed
• ImageReady(TM) MR Conditional Pacing System Clinical Study — Completed
• World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
• Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC) — Completed
• Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury — Completed
• Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3 — Completed
• High Dose Vitamin C in Cardiac Surgery Patients — Stopped early
• Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) — Stopped early
• Transplant Patient Registry of Liver, Kidney and/or Pancreas — Completed
• Continued Access Protocol — Completed
• Safety and Clinical Performance of the Protecta ICD and CRT-D — Completed
• REducing Anxiety in CHildren Undergoing Procedures — Completed
• DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery — Stopped early
• Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease — Completed
• Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD) — Completed
• Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. — Completed
• Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia — Completed
• Procurement of Blood Samples for a Biomedical Research Program on T Cell Functional Response to Chronic HBV Infection — Status unconfirmed
• Islet After Kidney Transplant for Type 1 Diabetes — Withdrawn before enrolling
• Hepatocyte Transplantation in Liver Failure — Withdrawn before enrolling
• ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis — Stopped early
• Iloprost Power Disc-15 in Pulmonary Arterial Hypertension — Stopped early
• ELEVATE (Evaluation of Left Ventricular Autothreshold) 3.0 — Completed